Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ)
CNY 17.47
(0.17%)
CNY 17.47
(0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 392.49 Million | 4.01 Billion | 1.12 Billion | 359.68 Million | 22.48 Million | 53.67 Million |
| Net Income | 69.21 Million | 4.38 Billion | 1.44 Billion | 475.62 Million | 42.5 Million | 62.46 Million |
| Depreciation & Amortization | 83.39 Million | 59.07 Million | 23.62 Million | 17.23 Million | 16.77 Million | 13.18 Million |
| Deferred income taxes | -27.71 Million | -130.48 Million | -7.01 Million | -6.68 Million | -1.12 Million | 1.28 Million |
| Stock-based compensation | 9.43 Million | 27.93 Million | 76.8 Million | 29.81 Million | - | - |
| Change in working capital | 269.13 Million | -1.38 Billion | -365.99 Million | -139.71 Million | -33.58 Million | -20.81 Million |
| Other non-cash items | 20.81 Million | 1.06 Billion | -47.1 Million | -16.6 Million | -3.2 Million | -1.17 Million |
| Investing Cash Flow | -1.36 Billion | -2.23 Billion | -685.11 Million | -43.36 Million | -97.26 Million | -204.5 Million |
| Investments in PPE | -109.97 Million | -313.37 Million | -103.56 Million | -28.28 Million | -31.93 Million | -47.47 Million |
| Acquisitions | 146.36 Thousand | 1.92 Billion | 0.81 | 28.29 Million | 31.93 Million | 47.47 Million |
| Investment purchases | -5.2 Billion | -6.3 Billion | -2.2 Billion | -844.5 Million | -600 Million | -450 Million |
| Sales/Maturities of investments | 3.95 Billion | 4.38 Billion | 1.62 Billion | 829.4 Million | 534.66 Million | 292.96 Million |
| Other Investing Activities | -1.25 Billion | -1.92 Billion | - | -28.28 Million | -31.93 Million | -47.47 Million |
| Financing Cash Flow | -670.05 Million | -432.79 Million | 82.27 Million | 182.92 Million | -22.26 Million | 293.72 Million |
| Debt repayment | -101.38 Million | -53.41 Million | -141.5 Million | -141.5 Million | -2.78 Million | -5.38 Million |
| Dividends payments | -577.4 Million | -548.77 Million | -282.93 Million | -6.65 Million | -19.97 Million | -26.63 Million |
| Common Stock Repurchased | -532.32 Thousand | - | 2.59 Million | - | - | - |
| Common Stock Issuance | - | - | -2.59 Million | - | - | -3.91 Million |
| Other Financing Activities | 13.8 Million | 171.26 Million | 507.16 Million | 332.86 Million | 496 Thousand | 320.36 Million |
| Accounts receivables | 1.25 Billion | -2.32 Billion | -722.31 Million | -320.04 Million | -4.12 Million | -21.21 Million |
| Accounts payables | -1.3 Billion | 1.53 Billion | 530.2 Million | 265.58 Million | -8.87 Million | 3.94 Million |
| Inventory | 342.82 Million | -473.37 Million | -166.86 Million | -78.57 Million | -19.47 Million | -4.81 Million |
| Other working capital | 79.95 Million | -130.48 Million | -7.01 Million | -6.68 Million | -1.12 Million | -15.99 Million |
| Cash at beginning of period | 2.55 Billion | 1.19 Billion | 669.11 Million | 170.51 Million | 267.55 Million | 124.66 Million |
| Cash at end of period | 914.03 Million | 2.55 Billion | 1.19 Billion | 669.11 Million | 170.51 Million | 267.55 Million |
| Capital Expenditure | -109.97 Million | -313.37 Million | -103.56 Million | -28.28 Million | -31.93 Million | -47.47 Million |
| Effect of forex changes on cash | 1.26 Million | 19.47 Million | -3.19 Million | -638.63 Thousand | 5858.54 | 5833.70 |
| Net cash flow / Change in cash | -1.64 Billion | 1.36 Billion | 520.96 Million | 498.59 Million | -97.04 Million | 142.89 Million |
| Free Cash Flow | 282.52 Million | 3.69 Billion | 1.02 Billion | 331.39 Million | -9.45 Million | 6.19 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 15.77 Million | 33.11 Million | 32.05 Million | 69.21 Million | -70.37 Million | 32.72 Million |
| Depreciation & Amortization | - | 15.49 Million | 15.49 Million | 83.39 Million | 29.71 Million | -31.15 Million |
| Deferred income taxes | - | - | - | -27.71 Million | - | 471.34 Million |
| Stock-based compensation | - | - | - | 9.43 Million | 9.43 Million | -7.33 Million |
| Change in working capital | - | 133.74 Million | - | 269.13 Million | 1.59 Billion | -432.85 Million |
| Other non-cash items | 19.26 Million | -220.85 Million | 14.05 Million | 20.81 Million | 338.43 Million | 341.76 Million |
| Investing Cash Flow | -129.02 Million | 44.11 Million | -60.59 Million | -1.36 Billion | -1.62 Billion | -134.38 Million |
| Investments in PPE | -31.95 Million | -53.04 Million | -61.43 Million | -109.97 Million | -27.65 Million | -34.37 Million |
| Acquisitions | 302.57 Thousand | -9.84 Million | -4.65 Million | 146.36 Thousand | 1.73 Million | 90.88 Thousand |
| Investment purchases | -217.24 Million | -190 Million | - | -5.2 Billion | -2.53 Billion | -156.75 Million |
| Sales/Maturities of investments | 120 Million | 297 Million | 5.42 Million | 3.95 Billion | 932.53 Million | 56.64 Million |
| Other Investing Activities | -124.74 Thousand | 107.76 Million | 5.49 Million | -1.25 Billion | -1.6 Billion | 0.59 |
| Financing Cash Flow | -187.5 Million | -48.61 Million | -14.52 Million | -670.05 Million | -56.91 Million | -52.47 Million |
| Debt repayment | - | -8.51 Million | -13.63 Million | -101.38 Million | -69.76 Million | -51.46 Million |
| Dividends payments | - | -40.77 Million | -104.95 Thousand | -577.4 Million | -4.32 Million | -219.88 Thousand |
| Common Stock Repurchased | - | - | - | -532.32 Thousand | -532.32 Thousand | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -187.5 Million | -39.98 Million | -780.72 Thousand | 13.8 Million | 17.17 Million | -791.39 Thousand |
| Accounts receivables | - | 139.06 Million | - | 1.25 Billion | 1.25 Billion | -532.62 Million |
| Accounts payables | - | - | - | -1.3 Billion | - | - |
| Inventory | - | 37.36 Million | - | 342.82 Million | 342.82 Million | 99.77 Million |
| Other working capital | - | -42.68 Million | - | 79.95 Million | - | - |
| Cash at beginning of period | 778.45 Million | 985.87 Million | 914.03 Million | 2.55 Billion | 2.36 Billion | 2.17 Billion |
| Cash at end of period | 494.48 Million | 778.45 Million | 884.22 Million | 914.03 Million | 914.03 Million | 2.36 Billion |
| Capital Expenditure | -31.95 Million | -53.04 Million | -61.43 Million | -109.97 Million | -27.65 Million | -34.37 Million |
| Effect of forex changes on cash | - | 313.06 Thousand | -376.41 Thousand | 1.26 Million | 60.1 Thousand | -639.63 Thousand |
| Net cash flow / Change in cash | -283.96 Million | -207.42 Million | -29.81 Million | -1.64 Billion | -1.45 Billion | 186.98 Million |
| Free Cash Flow | 3.09 Million | -256.28 Million | -15.32 Million | 282.52 Million | 210.69 Million | 340.11 Million |
603617
0411
LIXT
GRBMF
000651
6AX